Prior immunization of hamsters with three heterologous flaviviruses (Japanese encephalitis virus [JEV] SA14-2-8 vaccine, wild-type St. Louis encephalitis virus [SLEV], and Yellow fever virus [YFV] 17D vaccine) reduces the severity of subsequent West Nile virus (WNV) infection. Groups of adult hamsters were immunized with each of the heterologous flaviviruses; approximately 30 days later, the animals were injected intraperitoneally with a virulent New York strain of WNV. Subsequent levels of viremia, antibody response, and deaths were compared with those in nonimmune (control) hamsters. Immunity to JEV and SLEV was protective against clinical encephalitis and death after challenge with WNV. The antibody response in the sequentially infected hamsters also illustrates the difficulty in making a serologic diagnosis of WNV infection in animals (or humans) with preexisting Flavivirus immunity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732478 | PMC |
| http://dx.doi.org/10.3201/eid0803.010238 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of the heterologous expression, localization, and cellular response to the Zika virus E protein in vitro.
Cell Mol Biol (Noisy-le-grand)
November 2024
Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados del IPN, CDMX 07360, México.
Zika virus (ZIKV) infection has been associated with damage to neural stem cells in microcephaly in newborns. The virus possesses specific tropism for glioma stem cells mediated by the ZIKV E protein. This infection causes endoplasmic reticulum stress and activation of the unfolded protein response (UPR).
View Article and Find Full Text PDFAn engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice.
Front Microbiol
November 2024
School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, China.
Article Synopsis
- The study investigates the effects of antibodies from Japanese encephalitis virus (JEV) and Zika virus (ZIKV) infections on each other, focusing on a phenomenon called antibody-dependent enhancement (ADE), where the presence of one virus's antibodies can worsen the infection by the other virus.* -
- Researchers created modified vaccine candidates using recombinant adenoviruses and mRNA to examine their effectiveness in generating immune responses against JEV and the potential for cross-reactivity with ZIKV, finding that certain modifications lead to a reduced risk of ADE.* -
- Immunization with the modified vaccine candidates resulted in lower cross-reactive antibody levels and effective T cell responses, indicating that these vaccines could protect against JEV while minimizing the dangers
Potential role of heterologous flavivirus immunity in preventing urban transmission of yellow fever virus.
Nat Commun
November 2024
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Article Synopsis
- Recent yellow fever outbreaks in Brazil were linked to mosquito transmission but showed no human outbreaks due to a lack of vaccination and presence of Aedes aegypti mosquitoes.
- The study tested if immunity from dengue and Zika viruses impacts yellow fever virus (YFV) spread in monkeys, finding that prior infections reduced YFV levels in the blood.
- These findings suggest that immunity from other flaviviruses might help prevent the amplification and spread of yellow fever in populations already exposed to dengue and Zika.
Dengue Virus Infection: Immune Response and Therapeutic Targets.
Am J Trop Med Hyg
January 2025
Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Flavivirus infection, especially dengue virus infection caused by DENV, is known to be a significant health concern globally owing to the high incidence and mortality rate. The expanding and increasing disease burden calls for the need to develop an effective treatment and prevent the event of fatal complications, including dengue hemorrhagic fever/dengue shock syndrome. The DENV-induced immune response has been described as paradoxical because it has a protective role in viral clearance but, at the same time, causes more severe infection through viral-specific immunity.
View Article and Find Full Text PDFB cell receptor dependent enhancement of dengue virus infection.
PLoS Pathog
October 2024
Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, United States of America.
Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate entry of DENV into FcγR expressing cells such as monocytes, macrophages, and dendritic cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!